Observational studyAnnals of hematology2017

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.

Lotta Hansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.